From viral injury to chronic instability: recurrent COPD exacerbations after COVID-19

類似資料

• AM/PM dosing of LAMA for COPD: a randomized controlled trial protocol using digital recruitment and registries
  著者:: Pradeesh Sivapalan, 等
  出版事項: (2024-08-01)
• Treatment with prophylactic oral anticoagulants and the risk of mortality in COVID-19 patients: a nationwide cohort study
  著者:: Sarah Altaraihi, 等
  出版事項: (2023-05-01)
• From viral injury to chronic instability: recurrent COPD exacerbations after COVID-19
  著者:: Christian Kjer Heerfordt, 等
  出版事項: (2026-05-01)
• Evening administration of long-acting muscarinic antagonists in COPD – a randomized controlled trial
  著者:: Pradeesh Sivapalan, 等
  出版事項: (2025-12-01)
• Promising treatment biomarkers in asthma
  著者:: Barbara Bonnesen, 等
  出版事項: (2023-11-01)